Clinical Trials Directory

Trials / Completed

CompletedNCT03868579

Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing Pleuroscopy

A Pilot Study to Evaluate the Diagnostic Performance of Pleural Touch Preparations in Pleuroscopy, a Prospective Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
97 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial studies how well rapid on site evaluation of pleural touch preparations works in diagnosing cancerous fluid in between the linings of the lungs (malignant pleural effusion) in patients undergoing a pleuroscopy. A type of laboratory testing called rapid on site evaluation of pleural touch preparations that uses pleural biopsy tissue samples collected during an already-scheduled pleuroscopy may be able to diagnose malignant pleural effusion.

Detailed description

PRIMARY OBJECTIVES: I. To estimate the specificity of rapid on site evaluation (ROSE) of touch preparations (preps) for predicting malignancy on final pathology in pleuroscopy. SECONDARY OBJECTIVES: I. To estimate the sensitivity of rapid on site evaluation (ROSE) of touch preparations (preps) for predicting malignancy on final pathology in pleuroscopy. II. To estimate the specificity and sensitivity of visual assessment of pleura for predicting malignancy on final pathology in pleuroscopy. III. To compare the specificity and sensitivity of ROSE of touch preps between centers. OUTLINE: Patients undergo biopsy of the lining of the lung using pleuroscopy. Medical chart of patients is also reviewed.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiopsyUndergo biopsy
OTHERMedical Chart ReviewReview medical chart
PROCEDUREThoracoscopyUndergo pleuroscopy

Timeline

Start date
2018-01-10
Primary completion
2025-02-27
Completion
2025-02-27
First posted
2019-03-11
Last updated
2025-03-05

Locations

4 sites across 2 countries: United States, Cyprus

Source: ClinicalTrials.gov record NCT03868579. Inclusion in this directory is not an endorsement.